Sun, J., Wu, D., Zheng, L., Wang, H., Zhou, J., Shi, G., . . . Wang, J. Off-the-shelf CAR-NK cells targeting immunogenic cell death marker ERp57 execute robust antitumor activity and have a synergistic effect with ICD inducer oxaliplatin. BMJ Publishing Group.
Chicago Style (17th ed.) CitationSun, Jichao, et al. Off-the-shelf CAR-NK Cells Targeting Immunogenic Cell Death Marker ERp57 Execute Robust Antitumor Activity and Have a Synergistic Effect with ICD Inducer Oxaliplatin. BMJ Publishing Group.
MLA (9th ed.) CitationSun, Jichao, et al. Off-the-shelf CAR-NK Cells Targeting Immunogenic Cell Death Marker ERp57 Execute Robust Antitumor Activity and Have a Synergistic Effect with ICD Inducer Oxaliplatin. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.